首页> PloS one> Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Antonio,Giordano

第一单位： Department of Medicine, Division of Hematology & Oncology, Medical University of South Carolina, Charleston, South Carolina, United States of America.

作者： Antonio,Giordano ^[1] ; Yueying,Liu ^[1] ; Kent,Armeson ^[2] ; Yeonhee,Park ^[2] ; Maya,Ridinger ^[3] ; Mark,Erlander ^[3] ; James,Reuben ^[4] ; Carolyn,Britten ^[1] ; Christiana,Kappler ^[5] ; Elizabeth,Yeh ^[6] ; Stephen,Ethier ^[5]

作者单位： Department of Medicine, Division of Hematology & Oncology, Medical University of South Carolina, Charleston, South Carolina, United States of America. ^[1] Department of Public Health Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, United States of America. ^[2] Trovagene Oncology, San Diego, California, United States of America. ^[3] Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. ^[4] Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America. ^[5] Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indianapolis, United States of America. ^[6]